Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis

计划入组 24 人 · 首次发布于 2009 年 1 月 19 日

Plasma NGAL in APN Patients

计划入组 120 人 · 首次发布于 2025 年 1 月 31 日

[18F]APN-1607 PET in Subjects With AD Compared to HC

计划入组 230 人 · 首次发布于 2022 年 9 月 16 日

4SCAR-CD13

APN-850297

APN-959038

Arvinas Estrogen Receptor, Inc.

United States

Arvinas Androgen Receptor, Inc.

United States

Veru Inc

United States

Delta-Fly Pharma's DFP-14323 Phase III Trial Progresses with Afatinib Recommendation

Ciloa Secures €6.5 Million French Government Funding to Advance Novel Adiponectin-Based Therapy for Obesity and Type 2 Diabetes

Real-World Study Affirms Palbociclib's Efficacy in Chinese HR+/HER2- Metastatic Breast Cancer Patients